2705, boulevard Laurier
R0-709
Québec, Québec
Canada G1V 4G2
Dernières nouvelles
- Valiquette, JustinStagiaireCHUL+1 418-525-4444justin.valiquette@crchudequebec.ulaval.ca
2705, boulevard Laurier
Québec, QC
Canada G1V 4G2
An adaptable platform for in-house hepatitis C serology
Article de revueJ Virol Methods, 308 , 2022.
Impact of HCV cure on depressive symptoms in the HIV-HCV co-infected population in Canada
Article de revueClin Infect Dis, 2022.
Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian Registry
Article de revueClin Infect Dis, 72 (11), 2021.
To Induce Immune Reconstitution Inflammatory Syndrome or Suppress It: The Spectrum of Mycobacterium genavense in the Antiretroviral Era
Article de revueClin Infect Dis, 72 (2), 2021.
Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants
Article de revueBMC Public Health, 20 (1), 2020.
Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus
Article de revueClin Infect Dis, 71 (2), 2020.
Molecular surveillance of hepatitis C virus genotypes identifies the emergence of a genotype 4d lineage among men in Quebec, 2001-2017
Article de revueCan Commun Dis Rep, 45 (9), 2019.
Hepatitis C virus cure does not impact kidney function decline in HIV co-infected patients
Article de revueAIDS, 32 (6), 2018.
Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study
Article de revueClin Infect Dis, 65 (1), 2017.
Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV
Article de revueClin Infect Dis, 64 (9), 2017.
Projets actifs
- Optimiser le dépistage des populations vulnérables par goutte de sang séché, du 2022-01-15 au 2024-10-15
- Surveillance des réponses immunitaires au vaccin contre la COVID-19 chez les personnes vivant avec le VIH-1, du 2021-12-01 au 2022-11-30
Projets terminés récemment
- The National CIHR Hepatisis C Network (NCHCN), du 2015-04-01 au 2021-10-31